(INNF)
TIXAGEVIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-453) [VH (HOMO SAPIENS IGHV1-58*01 (98.0%) -(IGHD) -IGHJ3*02 (93.8%)) CDR-IMGT [8.8.16] (26-33.51-58.97-112) (1-123) -HOMO SAPIENS IGHG1*03 G1M3, NG1M1, G1V21 CH2 Y15.1, T16, E18, G1V39 CH2 F1.3, E1.2, S116 (CH1 R120 (220) (124-221), HINGE 1-15 (222-236), CH2 L1.3>F (240), L1.2>E (241), M15.1>Y (258), S16>T (260), T18>E (262), P116>S (337) (237-346), CH3 E12 (362), M14 (364) (347-451), CHS (452-453)) (124-453)], (226-216')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-216') [V-KAPPA (HOMO SAPIENS IGKV3-20*01 (98.9%) - IGKJ1*01 (100%)) CDR-IMGT [7.3.10] (27-33.51-53.90-99) (1'-109') - HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (155), V101 (193) (110'- 216')]; DIMER (232-232":235-235")-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA(WHO)
TIXAGEVIMABUM(INN)